Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation
A 29-year-old man with malignant lymphoma developed membranous nephropathy (MN) after allogeneic bone-marrow transplantation (BMT). There had been no obvious findings of graft versus host diseases (GVHD) after BMT, and the dosage of immunosuppressant drugs had not been reduced during this period. At...
Gespeichert in:
| Veröffentlicht in: | Clinical and experimental nephrology 2009-04, Vol.13 (2), p.174-178 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 178 |
|---|---|
| container_issue | 2 |
| container_start_page | 174 |
| container_title | Clinical and experimental nephrology |
| container_volume | 13 |
| creator | Sakai, Kentaro Usui, Joichi Kai, Hirayasu Hagiwara, Masahiro Morito, Naoki Saito, Chie Yoh, Keigyou Tsuruoka, Syuichi Hirayama, Kouichi Aita, Kumi Nagata, Michio Yamagata, Kunihiro |
| description | A 29-year-old man with malignant lymphoma developed membranous nephropathy (MN) after allogeneic bone-marrow transplantation (BMT). There had been no obvious findings of graft versus host diseases (GVHD) after BMT, and the dosage of immunosuppressant drugs had not been reduced during this period. At the onset of MN, a few lymphoma cells still remained in the bone marrow; the patient achieved complete remission of MN after the disappearance of the lymphoma cells. In this case it is suggested that immune complexes including antigens expressed by lymphoma cells might induce MN. Therefore, this is a significant case that may reveal an alternative mechanism of the onset of MN related to BMT. |
| doi_str_mv | 10.1007/s10157-008-0120-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67149882</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21185123</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-af71f67de2263f1f1757a5d40f6b5a013e2c4bcc0b1b48d296169be0549d83c3</originalsourceid><addsrcrecordid>eNqNkc1q3DAUhU1paNKkD9BNEV1050ZXtixrWUL_INBFsheyfD2jIEuuJBMmD9DnrswMBAqlXemCvnOujk5VvQX6ESgV1wkocFFT2tcUGK2fXlQX0DaiFkLKl2VuWlaD4HBevU7pgRZQcvmqOgcJQDvOL6pfd2iCH3U8kBnnIWof1kR2LswYVxc8Lvtos01EpxSM1RlH8mjznkQ0drHoc5mSHVftiDvMyz7Mmhh0riimjJFo58IOPVpDhmJHZh1jeCS5bEqL0z7rbIO_qs4m7RK-OZ2X1f2Xz_c33-rbH1-_33y6rQ1vZK71JGDqxIiMdc0EU8kmNB9bOnUD1xQaZKYdjKEDDG0_MtlBJwekvJVj35jmsvpwtF1i-Lliymq2aXut9lhyq05AK_ue_RNkAD0H1vwPKETfbOD7P8CHsEZfwhamh81MFAiOkIkhpYiTWqItP3ZQQNVWuTpWrkqTaqtcPRXNu5PxOsw4PitOHReAHYFUrvwO4_Pmv7v-BoF4up4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218151237</pqid></control><display><type>article</type><title>Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Sakai, Kentaro ; Usui, Joichi ; Kai, Hirayasu ; Hagiwara, Masahiro ; Morito, Naoki ; Saito, Chie ; Yoh, Keigyou ; Tsuruoka, Syuichi ; Hirayama, Kouichi ; Aita, Kumi ; Nagata, Michio ; Yamagata, Kunihiro</creator><creatorcontrib>Sakai, Kentaro ; Usui, Joichi ; Kai, Hirayasu ; Hagiwara, Masahiro ; Morito, Naoki ; Saito, Chie ; Yoh, Keigyou ; Tsuruoka, Syuichi ; Hirayama, Kouichi ; Aita, Kumi ; Nagata, Michio ; Yamagata, Kunihiro</creatorcontrib><description>A 29-year-old man with malignant lymphoma developed membranous nephropathy (MN) after allogeneic bone-marrow transplantation (BMT). There had been no obvious findings of graft versus host diseases (GVHD) after BMT, and the dosage of immunosuppressant drugs had not been reduced during this period. At the onset of MN, a few lymphoma cells still remained in the bone marrow; the patient achieved complete remission of MN after the disappearance of the lymphoma cells. In this case it is suggested that immune complexes including antigens expressed by lymphoma cells might induce MN. Therefore, this is a significant case that may reveal an alternative mechanism of the onset of MN related to BMT.</description><identifier>ISSN: 1342-1751</identifier><identifier>EISSN: 1437-7799</identifier><identifier>DOI: 10.1007/s10157-008-0120-z</identifier><identifier>PMID: 19110655</identifier><identifier>CODEN: CENPFV</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Adult ; Bone Marrow Transplantation - adverse effects ; Bone Marrow Transplantation - immunology ; Case Report ; Glomerulonephritis, Membranous - etiology ; Glomerulonephritis, Membranous - immunology ; Humans ; Immunoglobulin G - immunology ; Kidney - immunology ; Kidney - pathology ; Lymphoma - complications ; Lymphoma - immunology ; Lymphoma - therapy ; Male ; Medicine ; Medicine & Public Health ; Neoplasm, Residual - complications ; Neoplasm, Residual - immunology ; Nephrology ; Remission Induction ; Transplantation, Homologous ; Urology</subject><ispartof>Clinical and experimental nephrology, 2009-04, Vol.13 (2), p.174-178</ispartof><rights>Japanese Society of Nephrology 2008</rights><rights>Japanese Society of Nephrology 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-af71f67de2263f1f1757a5d40f6b5a013e2c4bcc0b1b48d296169be0549d83c3</citedby><cites>FETCH-LOGICAL-c539t-af71f67de2263f1f1757a5d40f6b5a013e2c4bcc0b1b48d296169be0549d83c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10157-008-0120-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10157-008-0120-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19110655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakai, Kentaro</creatorcontrib><creatorcontrib>Usui, Joichi</creatorcontrib><creatorcontrib>Kai, Hirayasu</creatorcontrib><creatorcontrib>Hagiwara, Masahiro</creatorcontrib><creatorcontrib>Morito, Naoki</creatorcontrib><creatorcontrib>Saito, Chie</creatorcontrib><creatorcontrib>Yoh, Keigyou</creatorcontrib><creatorcontrib>Tsuruoka, Syuichi</creatorcontrib><creatorcontrib>Hirayama, Kouichi</creatorcontrib><creatorcontrib>Aita, Kumi</creatorcontrib><creatorcontrib>Nagata, Michio</creatorcontrib><creatorcontrib>Yamagata, Kunihiro</creatorcontrib><title>Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation</title><title>Clinical and experimental nephrology</title><addtitle>Clin Exp Nephrol</addtitle><addtitle>Clin Exp Nephrol</addtitle><description>A 29-year-old man with malignant lymphoma developed membranous nephropathy (MN) after allogeneic bone-marrow transplantation (BMT). There had been no obvious findings of graft versus host diseases (GVHD) after BMT, and the dosage of immunosuppressant drugs had not been reduced during this period. At the onset of MN, a few lymphoma cells still remained in the bone marrow; the patient achieved complete remission of MN after the disappearance of the lymphoma cells. In this case it is suggested that immune complexes including antigens expressed by lymphoma cells might induce MN. Therefore, this is a significant case that may reveal an alternative mechanism of the onset of MN related to BMT.</description><subject>Adult</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Bone Marrow Transplantation - immunology</subject><subject>Case Report</subject><subject>Glomerulonephritis, Membranous - etiology</subject><subject>Glomerulonephritis, Membranous - immunology</subject><subject>Humans</subject><subject>Immunoglobulin G - immunology</subject><subject>Kidney - immunology</subject><subject>Kidney - pathology</subject><subject>Lymphoma - complications</subject><subject>Lymphoma - immunology</subject><subject>Lymphoma - therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasm, Residual - complications</subject><subject>Neoplasm, Residual - immunology</subject><subject>Nephrology</subject><subject>Remission Induction</subject><subject>Transplantation, Homologous</subject><subject>Urology</subject><issn>1342-1751</issn><issn>1437-7799</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc1q3DAUhU1paNKkD9BNEV1050ZXtixrWUL_INBFsheyfD2jIEuuJBMmD9DnrswMBAqlXemCvnOujk5VvQX6ESgV1wkocFFT2tcUGK2fXlQX0DaiFkLKl2VuWlaD4HBevU7pgRZQcvmqOgcJQDvOL6pfd2iCH3U8kBnnIWof1kR2LswYVxc8Lvtos01EpxSM1RlH8mjznkQ0drHoc5mSHVftiDvMyz7Mmhh0riimjJFo58IOPVpDhmJHZh1jeCS5bEqL0z7rbIO_qs4m7RK-OZ2X1f2Xz_c33-rbH1-_33y6rQ1vZK71JGDqxIiMdc0EU8kmNB9bOnUD1xQaZKYdjKEDDG0_MtlBJwekvJVj35jmsvpwtF1i-Lliymq2aXut9lhyq05AK_ue_RNkAD0H1vwPKETfbOD7P8CHsEZfwhamh81MFAiOkIkhpYiTWqItP3ZQQNVWuTpWrkqTaqtcPRXNu5PxOsw4PitOHReAHYFUrvwO4_Pmv7v-BoF4up4</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Sakai, Kentaro</creator><creator>Usui, Joichi</creator><creator>Kai, Hirayasu</creator><creator>Hagiwara, Masahiro</creator><creator>Morito, Naoki</creator><creator>Saito, Chie</creator><creator>Yoh, Keigyou</creator><creator>Tsuruoka, Syuichi</creator><creator>Hirayama, Kouichi</creator><creator>Aita, Kumi</creator><creator>Nagata, Michio</creator><creator>Yamagata, Kunihiro</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20090401</creationdate><title>Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation</title><author>Sakai, Kentaro ; Usui, Joichi ; Kai, Hirayasu ; Hagiwara, Masahiro ; Morito, Naoki ; Saito, Chie ; Yoh, Keigyou ; Tsuruoka, Syuichi ; Hirayama, Kouichi ; Aita, Kumi ; Nagata, Michio ; Yamagata, Kunihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-af71f67de2263f1f1757a5d40f6b5a013e2c4bcc0b1b48d296169be0549d83c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Bone Marrow Transplantation - immunology</topic><topic>Case Report</topic><topic>Glomerulonephritis, Membranous - etiology</topic><topic>Glomerulonephritis, Membranous - immunology</topic><topic>Humans</topic><topic>Immunoglobulin G - immunology</topic><topic>Kidney - immunology</topic><topic>Kidney - pathology</topic><topic>Lymphoma - complications</topic><topic>Lymphoma - immunology</topic><topic>Lymphoma - therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasm, Residual - complications</topic><topic>Neoplasm, Residual - immunology</topic><topic>Nephrology</topic><topic>Remission Induction</topic><topic>Transplantation, Homologous</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakai, Kentaro</creatorcontrib><creatorcontrib>Usui, Joichi</creatorcontrib><creatorcontrib>Kai, Hirayasu</creatorcontrib><creatorcontrib>Hagiwara, Masahiro</creatorcontrib><creatorcontrib>Morito, Naoki</creatorcontrib><creatorcontrib>Saito, Chie</creatorcontrib><creatorcontrib>Yoh, Keigyou</creatorcontrib><creatorcontrib>Tsuruoka, Syuichi</creatorcontrib><creatorcontrib>Hirayama, Kouichi</creatorcontrib><creatorcontrib>Aita, Kumi</creatorcontrib><creatorcontrib>Nagata, Michio</creatorcontrib><creatorcontrib>Yamagata, Kunihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakai, Kentaro</au><au>Usui, Joichi</au><au>Kai, Hirayasu</au><au>Hagiwara, Masahiro</au><au>Morito, Naoki</au><au>Saito, Chie</au><au>Yoh, Keigyou</au><au>Tsuruoka, Syuichi</au><au>Hirayama, Kouichi</au><au>Aita, Kumi</au><au>Nagata, Michio</au><au>Yamagata, Kunihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation</atitle><jtitle>Clinical and experimental nephrology</jtitle><stitle>Clin Exp Nephrol</stitle><addtitle>Clin Exp Nephrol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>13</volume><issue>2</issue><spage>174</spage><epage>178</epage><pages>174-178</pages><issn>1342-1751</issn><eissn>1437-7799</eissn><coden>CENPFV</coden><abstract>A 29-year-old man with malignant lymphoma developed membranous nephropathy (MN) after allogeneic bone-marrow transplantation (BMT). There had been no obvious findings of graft versus host diseases (GVHD) after BMT, and the dosage of immunosuppressant drugs had not been reduced during this period. At the onset of MN, a few lymphoma cells still remained in the bone marrow; the patient achieved complete remission of MN after the disappearance of the lymphoma cells. In this case it is suggested that immune complexes including antigens expressed by lymphoma cells might induce MN. Therefore, this is a significant case that may reveal an alternative mechanism of the onset of MN related to BMT.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>19110655</pmid><doi>10.1007/s10157-008-0120-z</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1342-1751 |
| ispartof | Clinical and experimental nephrology, 2009-04, Vol.13 (2), p.174-178 |
| issn | 1342-1751 1437-7799 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67149882 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Bone Marrow Transplantation - adverse effects Bone Marrow Transplantation - immunology Case Report Glomerulonephritis, Membranous - etiology Glomerulonephritis, Membranous - immunology Humans Immunoglobulin G - immunology Kidney - immunology Kidney - pathology Lymphoma - complications Lymphoma - immunology Lymphoma - therapy Male Medicine Medicine & Public Health Neoplasm, Residual - complications Neoplasm, Residual - immunology Nephrology Remission Induction Transplantation, Homologous Urology |
| title | Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A40%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Secondary%20membranous%20glomerulonephritis%20associated%20with%20recipient%20residual%20lymphoma%20cells%20after%20allogeneic%20bone%20marrow%20transplantation&rft.jtitle=Clinical%20and%20experimental%20nephrology&rft.au=Sakai,%20Kentaro&rft.date=2009-04-01&rft.volume=13&rft.issue=2&rft.spage=174&rft.epage=178&rft.pages=174-178&rft.issn=1342-1751&rft.eissn=1437-7799&rft.coden=CENPFV&rft_id=info:doi/10.1007/s10157-008-0120-z&rft_dat=%3Cproquest_cross%3E21185123%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218151237&rft_id=info:pmid/19110655&rfr_iscdi=true |